Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Accounts Payables (2021 - 2025)

Core Scientific's Accounts Payables history spans 5 years, with the latest figure at $212.2 million for Q3 2025.

  • For Q3 2025, Accounts Payables rose 3162.28% year-over-year to $212.2 million; the TTM value through Sep 2025 reached $212.2 million, up 3162.28%, while the annual FY2024 figure was $19.3 million, 87.55% down from the prior year.
  • Accounts Payables for Q3 2025 was $212.2 million at Core Scientific, down from $215.1 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $215.1 million in Q2 2025 and bottomed at $86179.0 in Q1 2021.
  • The 5-year median for Accounts Payables is $19.3 million (2024), against an average of $49.8 million.
  • The largest annual shift saw Accounts Payables soared 18028.55% in 2022 before it crashed 87.55% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $11.6 million in 2021, then soared by 361.75% to $53.6 million in 2022, then soared by 188.49% to $154.8 million in 2023, then plummeted by 87.55% to $19.3 million in 2024, then surged by 1001.37% to $212.2 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Accounts Payables are $212.2 million (Q3 2025), $215.1 million (Q2 2025), and $6.3 million (Q1 2025).